July 7, 2023
CMS Posted New Study for Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer’s Disease (AD)
The Centers for Medicare & Medicaid Services (CMS) has posted a new study for treatment of Alzheimer’s Disease (AD).
Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer’s Disease (AD)
New Alzheimer’s Drug Fact Sheets for Providers and Patients – Please scroll to bottom of page